axetis.com
Axetis :: MANAGEMENT TEAM
http://axetis.com/index.php/team
SILVIO SCHAFFNER - CEO. CARLO CIVELLI - COO - BOARDMEMBER - CHAIRMAN. Has more than 35 years of experience in international investment banking and financing services. He was engaged in different companies including two US broker companies and in 1980 founded Clarion Finanz AG, a financing company with the focus to offer venture capital to young start-up companies and to support such companies to reach IPO. NICOLAS MATHYS - CFO - BOARDMEMBER. DR AXEL SONNENFELD - CTO. OLIVER HOLZER - BOARDMEMBER.
axetis.com
Axetis :: VISION
http://axetis.com/index.php/vision
A leading company in innovation of medical devices for cardiovascular therapies. The first company to develop and sell a novel bio-inert, nano-surface treated coronary stent system with improved biocompatibility and therefore reduced foreign body reactions, to reduce neointimal hyperplasia leading to a reduced risk of restenosis compared to current stents. World’s first novel bio-inert, nano-surface treated coronary stent system. Novel stent design without foreshortening for ideal stent placement.
axetis.com
Axetis :: ADVISORY BOARD
http://axetis.com/index.php/advisory-board
BEST IN CLASS BRAIN POOL. SIMON PHILIPP HOERSTRUP, PROF. MD, PHD. BRUNO COVELLI, DR. GREGOR ZÜND, PROF. MD. PHILIPP RUDOLF VON ROHR, PROF. Is professor for process engineering at ETH Zurich since 1992. He has a long experience. PATRICK SERRUYS, PROF. MD, PHD - CLINICAL RESEARCH.